Predictors of Virological Response to a Combination Therapy with Pegylated Interferon Plus Ribavirin Including Virus and Host Factors
Figure 5
The rate of EVR in the patients with genotype 1b and high levels of HCVRNA, based on fatty deposition in the liver (a), and the LDL cholesterol value (b), respectively. EVR was highly achieved in the patients with less steatosis in the liver, and in those with high serum LDL-cholesterol levels. This is univariate analysis, and cited from [36].
